1248.0 - Australian Standard Classification of Drugs of Concern, 2011
Latest ISSUE Released at 11:30 AM (CANBERRA TIME) 06/07/2011
|Page tools: Print Page Print All RSS Search this Product|
NEED FOR REVIEW
The need for periodic reviews of the ASCDC to reflect the changes in the types of drugs of concern being used and the prevalence of drug usage in Australia was foreshadowed when the ASCDC was released. Feedback from key users of the ASCDC highlighted the need for a review of the ASCDC to ensure it is up to date. Accordingly the ABS undertook a review of the ASCDC in 2009.
PURPOSE OF THE REVIEW
The purpose of the review was to:
Extensive research was conducted to:
Three rounds of Stakeholder Consultation were held to determine any shortcomings with the current ASCDC and to establish which, if any, new drugs needed to be included in the classification.
To limit disruption to time series and to create as little confusion as possible, drugs separately identified in the first edition have mainly retained the same code in the Second Edition; only being allocated new codes if they have been moved to a different group. Drugs separately identified for the first time have been allocated previously unused codes. Previously used codes have not been reallocated. One effect of the decision to keep drug codes constant over time is that the original alphabetical order of drugs within narrow groups has been disrupted in some instances.
These documents will be presented in a new window.